Give Dad the Gift of BBQ This Father's Day with Dickey's E-Gift Cards
Give Dad the Gift of BBQ This Father's Day with Dickey's E-Gift Cards
Dallas, TX, June 13, 2025 (GLOBE NEWSWIRE) -- This Father's Day, Dickey's Barbecue Restaurants is offering two special promotions that allow families to celebrate dads in the best way possible – through the love of great barbecue. Whether you're near a Dickey's or celebrating from afar, the restaurant's E-Gift Cards and exclusive discount make it easier than ever to share a meal with dad.
E-Gift Cards: The Perfect Gift for Dads Far and Near
For those unable to join in-person, Dickey's Barbecue is offering an easy and thoughtful solution – Dickey's E-Gift Cards. Customers can purchase e-gift cards HERE, allowing them to send the gift of delicious smoked barbecue directly to dad's inbox. Whether he's enjoying a meal at home or on the go, Dickey's has you covered.
'E-gift cards are a convenient and meaningful way to share the Dickey's experience with the special dads in your life, no matter where they are,' said Laura Rea Dickey, CEO of Dickey's Barbecue Restaurants, Inc. 'We want to make it easy for everyone to honor their fathers with a flavorful, memorable meal.'
Father's Day Special: 15% Off Orders Over $75
In addition to e-gift cards, Dickey's is offering 15% off orders of $75 or more. This offer is available with code LOVEDAD in-store, online at dickeys.com, and through the Dickey's mobile app. Perfect for those gathering family and friends together for a Father's Day feast, this discount ensures a delicious meal without the hassle.
'We're proud to offer these promotions that allow families to come together and celebrate fathers with great food,' said Roland Dickey, Jr., CEO of Dickey's Capital Group. 'As a third-generation leader of Dickey's, it's incredibly special to me to continue my family's legacy of serving up Texas barbecue. Father's Day is a time to honor the men who have shaped our lives, and there's no better way to do that than by sharing a plate of our signature smoked meats with the ones we love.'
Celebrate Father's Day with Dickey's Barbecue
From our family to yours, Dickey's Barbecue is here to help make Father's Day a deliciously memorable occasion. Whether you're near a Dickey's location or enjoying the ease of e-gift cards, take the opportunity to honor the dads in your life with a meal that's as flavorful as they are.
About Dickey's Barbecue Restaurants, Inc.
Founded in 1941 by the Dickey family, Dickey's Barbecue Restaurants, Inc. is the world's largest barbecue concept and continues as a third-generation family-run business. For more than 80 years, Dickey's Barbecue Pit has served millions with its signature Legit. Texas. Barbecue.™ Slow-smoked over hickory wood-burning pits, Dickey's barbecued meats are paired with a variety of Southern sides. Committed to authentic barbecue, Dickey's never takes shortcuts — because real barbecue can't be rushed.
With more than 866 restaurants across eight concepts in the U.S. and several countries, Dickey's Barbecue Franchise and Dickey's Restaurant Brands continue to grow under the leadership of Roland Dickey Jr., CEO of Dickey's Capital Group, and Laura Rea Dickey, CEO of Dickey's Barbecue Restaurants, Inc.
Dickey's has been recognized on Newsweek's 2022 "America's Favorite Restaurant Chains" list, Nation's Restaurant News 2024 top fast-casual brands for value, and USA Today's 2021 Readers' Choice Awards. The brand has also ranked in the Top 20 of Fast Casual's 'Top 100 Movers and Shakers' for four of the past five years. Additional accolades include Entrepreneur's Top 500 Franchise and Hospitality Technology's Industry Heroes list. The brand has been featured by Fox News, Forbes, Franchise Times, The Wall Street Journal, and People Magazine.
For more information, visit www.dickeys.com. For franchise opportunities, visit www.dickeysfranchise.com.
Attachment
Give Dad the Gift of BBQ This Father's Day with Dickey's E-Gift Cards
CONTACT: Louisa Garrett Dickey's Barbecue Pit lgarrett@dickeys.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
a minute ago
- Business Wire
Chewy Announces Fiscal Second Quarter 2025 Financial Results Conference Call
PLANTATION, Fla.--(BUSINESS WIRE)--Chewy, Inc. (NYSE: CHWY) ('Chewy'), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal second quarter 2025 financial results before the market opens on Wednesday, September 10, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed on the company's investor relations website at and a replay of the conference call will also be available on the company's investor relations website for at least 90 days following the event. Chewy Fiscal Second Quarter 2025 Financial Results Conference Call When: Wednesday, September 10, 2025 Time: 8:00 am ET Live webcast and replay: Conference call registration: Phone Registration Link About Chewy Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies and prescriptions as a result of our broad selection of high-quality products and services, which we offer at competitive prices and deliver with an exceptional level of care and a personal touch to build brand loyalty and drive repeat purchasing. We seek to continually develop innovative ways for our customers to engage with us, as our websites and mobile applications allow our pet parents to manage their pets' health, wellness, and merchandise needs, while enabling them to conveniently shop for our products. We partner with approximately 3,200 of the best and most trusted brands in the pet industry, and we create and offer our own private brands. Through our websites and mobile applications, we offer our customers approximately 130,000 products and services offerings, to bring what we believe is a high-bar, customer-centric experience to our customers.
Business Wire
31 minutes ago
- Business Wire
CHTR BREAKING NEWS: Charter Communications, Inc. 18% Stock Drop Results in Class Action -- Investors are Notified to Contact BFA Law by October 14 Class Action Deadline
NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) and certain of the Company's senior executives for potential violations of the federal securities laws. Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Charter Communications, Inc. (NASDAQ: CHTR) for potential violations of the federal securities laws. Share If you invested in Charter, you are encouraged to obtain additional information by visiting: Investors have until October 14, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Charter securities. The case is pending in the U.S. District Court for the Southern District of New York and is captioned Sandoval v. Charter Communications, Inc., No. 1:25-cv-06747. Why Was Charter Sued Under the Federal Securities Laws? Charter is a leading broadband, or high-speed internet, connectivity company and cable operator. Charter participated in the FCC's Affordable Connectivity Program ('ACP'), which provided funding to Charter in exchange for subsidizing high-speed internet plans for low-income households. In June 2024, lack of federal funding caused the ACP to end, which led to customer declines at Charter. During the relevant period, Charter told investors that the Company was executing a plan to minimize and move beyond risks that the end of the ACP had on customer declines and earnings. The Company stated that it had 'managed the end of the affordable connectivity program successfully' and that '[t]he impact of the elimination of the ACP is now behind us.' As alleged, in truth, the impact from the ACP's elimination was not behind Charter as the Company continued to experience internet customer and revenue declines from the program's end. The Stock Declines as the Truth Is Revealed On July 25, 2025, Charter announced its second quarter 2025 financial results. The Company reported that total internet customers decreased by 117,000 during the quarter, which included approximately 50,000 disconnects related to the end of the ACP, nearly double from the prior quarter. On this news, the price of Charter stock declined $70.25 per share, or 18.4%, from a closing price of $380.00 per share on July 24, 2025, to $309.75 per share on July 25, 2025. Click here for more information: . What Can You Do? If you invested in Charter you may have legal options and are encouraged to submit your information to the firm. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. Why Bleichmar Fonti & Auld LLP? BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named 'Elite Trial Lawyers' by the National Law Journal, among the top '500 Leading Plaintiff Financial Lawyers' by Lawdragon, 'Titans of the Plaintiffs' Bar' by Law360 and 'SuperLawyers' by Thomson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd. For more information about BFA and its attorneys, please visit Attorney advertising. Past results do not guarantee future outcomes.
Business Wire
31 minutes ago
- Business Wire
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit in the Unified Patent Court (UPC) of the European Union against Pfizer Inc. and certain of its subsidiaries (action number 35071/2025), seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid™ (nirmatrelvir tablets; ritonavir tablets). This enforcement action targets Pfizer's activities in the 18 countries of the European Union that are presently participating in the UPC. The European Patent Office's recent grant of the '265 Patent to Enanta was published in the European Patent Bulletin today. The '265 Patent is based on Enanta's July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists. The '265 Patent is the European counterpart of U.S. Patent No. 11,358,953 (the '953 Patent) involved in ongoing U.S. litigation between Enanta and Pfizer Inc. Under UPC procedures, a hearing on the infringement action is expected to occur within the UPC's published 12-month target, with the decision rendered within weeks thereafter. If the UPC determines there has been infringement, subsequent proceedings would be required to determine damages. All timelines remain subject to potential rights of appeal and other customary proceedings in European patent litigation. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET ® (U.S.) and MAVIRET ® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including statements with respect to Enanta's filing in the UPC of a suit against Pfizer Inc. and certain of its subsidiaries seeking a determination of liability for use and infringement of Enanta's patent and Enanta's expectations with respect to any further action with respect to such proceedings. Statements that are not historical facts are based on management's current expectations, estimates, forecasts and projections about Enanta's business and the industry in which it operates and management's beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including those covering one or more of its product candidates, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta's senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta's reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in 'Risk Factors' in Enanta's Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law.
